ClinicalTrials.Veeva

Menu

Effect of the Coughing Technique During Subcutaneous Heparin Injection

B

Bursa Uludag University

Status

Completed

Conditions

Colon Surgery
Cholecystectomy
Thyroidectomy
Inguinal Hernia

Treatments

Other: the medium intensity coughing technique

Study type

Interventional

Funder types

Other

Identifiers

NCT05681338
2022-6/18

Details and patient eligibility

About

Objective: to examine the effect of the medium intensity coughing technique during subcutaneous low molecular weight heparin injection on pain severity and individual satisfaction in general surgery patients. Method: a prospective, quasi-experimental study included 100 patients who had prescribed a subcutaneous low molecular weight heparin injection once in 24 hours. Each patient received two injections by the same researcher using standard injection technique with medium intensity coughing technique and only standard injection technique.

Full description

Aims and objectives: The aim of this study was to examine the effect on the level of pain severity and satisfaction of patients of the medium intensity coughing technique applied to patients during the administration of subcutaneous low molecular weight heparin (LMWH) injection.

Design: This research was a prospective quasi-experimental study. Methods: It was conducted with 100 patients in the General Surgery Clinic of a university hospital in the Marmara Region of Turkey. Subcutaneous LMWH injections were administered by the same nurse to the outer side of the right and left upper arms by the standard injection technique and the medium intensity coughing technique. Immediately after the subcutaneous LMWH injection was given, a researcher who did not know which injection method had been used asked the patients to evaluate their pain levels by the Visual Analog Scale (VAS) and their satisfaction with the performance of the injection by the Visual Individual Satisfaction Scale (VISS).

Enrollment

60 patients

Sex

All

Ages

22 to 86 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participating voluntarily in the study
  • Being over the age of 18,
  • Having a doctor's prescription for subcutaneous low molecular weight heparin 0.6 mL treatment and not yet having begun treatment.
  • Having no coagulation disorder, having no disorder that could affect pain perception, -
  • Having no incision, lipodystrophy, or finding of infection at the injection site,
  • Having no communication problem

Exclusion criteria

  • Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study
  • Having any condition which would affect the sensation of pain
  • Not being able to agree on a place or time
  • Being less than 18 years of age

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

60 participants in 2 patient groups

the medium intensity coughing technique
Experimental group
Description:
Immediately before the subcutaneous heparin injection was given, patients were asked to cough twice at a medium level. After that, they were asked to cough ten seconds later for a second time at the same level, and while they were coughing for the second time, the needle was inserted into the tissue.
Treatment:
Other: the medium intensity coughing technique
the standard injection technique
No Intervention group
Description:
During the subcutaneous heparin injection, patients were not asked to perform any action, and the injection was given by the standard technique.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems